Skip to main content
NCBI home page
Archives of Disease in Childhood logoLink to Archives of Disease in Childhood
. 1993 Apr;68(4):458–463. doi: 10.1136/adc.68.4.458

Growth and growth hormone secretion after bone marrow transplantation.

R Brauner 1, M Fontoura 1, J M Zucker 1, A Devergie 1, J C Souberbielle 1, C Prevot-Saucet 1, J Michon 1, E Gluckman 1, C Griscelli 1, A Fischer 1, et al.
PMCID: PMC1029264  PMID: 8503666

Abstract

This study analyses the growth and the growth hormone secretion of children given various conditioning protocols before bone marrow transplantation (BMT). Twenty nine children (14 boys, 15 girls) given BMT were classified according to their conditioning protocol: total body irradiation (TBI) given as a single exposure of 10 Grays (Gy, group I, 11 cases), or 8 Gy (group II, four cases), 12 Gy given as six fractionated doses (Group III, seven cases), or chemotherapy alone (group IV, seven cases). The arginine-insulin stimulated growth hormone peak, 2-7.5 years after BMT, was > 10 micrograms/l in all patients except four from group I (6.9-8.9 micrograms/l). A second growth hormone secretion evaluation was performed in 10 group I patients because of persistent low growth velocity despite a normal growth hormone peak. There were no significant changes in the mean (SEM) stimulated growth hormone peak (18.4 (2.2) v 20.1 (3.6) micrograms/l) at 3 (0.3) to 5.2 (0.6) years after BMT. The sleep growth hormone peaks and concentrations (n = 6) were normal. The mean cumulative height changes (SD) during the three years after BMT were: -1.4 (0.2) in group I, -0.1 (0.4) in group II, -0.4 (0.2) in group III, and 1.5 (0.5) in group IV; this was significant in groups I and IV. The final heights of two monozygotic twins (BMT donor and recipient) had differed by 17.5 cm, despite them both having normal growth hormone peaks and puberty. Eight patients, treated for congenital immune deficiency syndrome, were growth retarded at the time of BMT. Of these, only those conditioned by chemotherapy alone had significant catch up growth (2(0.6)SD) while those conditioned by a single Gy exposure did not (0(0.4)SD). It is concluded that the total radiation dose is critical for growth evolution, as is the fractionation schedule. For the TBI doses and the interval since BMT studied, there was no correlation between growth hormone peak and the height loss. The rapidity of decreased growth velocity after TBI and the comparison between the monozygotic twins suggest that radiation induced skeletal lesions are partly responsible for the decreased growth.

Full text

PDF
458

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Borgström B., Bolme P. Growth and growth hormone in children after bone marrow transplantation. Horm Res. 1988;30(2-3):98–100. doi: 10.1159/000181037. [DOI] [PubMed] [Google Scholar]
  2. Bortin M. M., Rimm A. A. Increasing utilization of bone marrow transplantation. Transplantation. 1986 Sep;42(3):229–234. doi: 10.1097/00007890-198609000-00001. [DOI] [PubMed] [Google Scholar]
  3. Brauner R., Rappaport R., Prevot C., Czernichow P., Zucker J. M., Bataini P., Lemerle J., Sarrazin D., Guyda H. J. A prospective study of the development of growth hormone deficiency in children given cranial irradiation, and its relation to statural growth. J Clin Endocrinol Metab. 1989 Feb;68(2):346–351. doi: 10.1210/jcem-68-2-346. [DOI] [PubMed] [Google Scholar]
  4. Bushhouse S., Ramsay N. K., Pescovitz O. H., Kim T., Robison L. L. Growth in children following irradiation for bone marrow transplantation. Am J Pediatr Hematol Oncol. 1989 Summer;11(2):134–140. [PubMed] [Google Scholar]
  5. Furlanetto R. W., Underwood L. E., Van Wyk J. J., D'Ercole A. J. Estimation of somatomedin-C levels in normals and patients with pituitary disease by radioimmunoassay. J Clin Invest. 1977 Sep;60(3):648–657. doi: 10.1172/JCI108816. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Hovi L., Rajantie J., Perkkiö M., Sainio K., Sipilä I., Siimes M. A. Growth failure and growth hormone deficiency in children after bone marrow transplantation for leukemia. Bone Marrow Transplant. 1990 Mar;5(3):183–186. [PubMed] [Google Scholar]
  7. Leiper A. D., Stanhope R., Lau T., Grant D. B., Blacklock H., Chessells J. M., Plowman P. N. The effect of total body irradiation and bone marrow transplantation during childhood and adolescence on growth and endocrine function. Br J Haematol. 1987 Dec;67(4):419–426. doi: 10.1111/j.1365-2141.1987.tb06163.x. [DOI] [PubMed] [Google Scholar]
  8. NEUHAUSER E. B. D., WITTENBORG M. H., BERMAN C. Z., COHEN J. Irradiation effects of roentgen therapy on the growing spine. Radiology. 1952 Nov;59(5):637–650. doi: 10.1148/59.5.637. [DOI] [PubMed] [Google Scholar]
  9. Ogilvy-Stuart A. L., Clark D. J., Wallace W. H., Gibson B. E., Stevens R. F., Shalet S. M., Donaldson M. D. Endocrine deficit after fractionated total body irradiation. Arch Dis Child. 1992 Sep;67(9):1107–1110. doi: 10.1136/adc.67.9.1107. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Papadimitriou A., Urena M., Hamill G., Stanhope R., Leiper A. D. Growth hormone treatment of growth failure secondary to total body irradiation and bone marrow transplantation. Arch Dis Child. 1991 Jun;66(6):689–692. doi: 10.1136/adc.66.6.689. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Rappaport R., Brauner R. Growth and endocrine disorders secondary to cranial irradiation. Pediatr Res. 1989 Jun;25(6):561–567. doi: 10.1203/00006450-198906000-00001. [DOI] [PubMed] [Google Scholar]
  12. Sanders J. E., Pritchard S., Mahoney P., Amos D., Buckner C. D., Witherspoon R. P., Deeg H. J., Doney K. C., Sullivan K. M., Appelbaum F. R. Growth and development following marrow transplantation for leukemia. Blood. 1986 Nov;68(5):1129–1135. [PubMed] [Google Scholar]
  13. Thomas E. D., Storb R., Clift R. A., Fefer A., Johnson L., Neiman P. E., Lerner K. G., Glucksberg H., Buckner C. D. Bone-marrow transplantation (second of two parts). N Engl J Med. 1975 Apr 24;292(17):895–902. doi: 10.1056/NEJM197504242921706. [DOI] [PubMed] [Google Scholar]
  14. Thomas E., Storb R., Clift R. A., Fefer A., Johnson F. L., Neiman P. E., Lerner K. G., Glucksberg H., Buckner C. D. Bone-marrow transplantation (first of two parts). N Engl J Med. 1975 Apr 17;292(16):832–843. doi: 10.1056/NEJM197504172921605. [DOI] [PubMed] [Google Scholar]
  15. Willi S. M., Cooke K., Goldwein J., August C. S., Olshan J. S., Moshang T., Jr Growth in children after bone marrow transplantation for advanced neuroblastoma compared with growth after transplantation for leukemia or aplastic anemia. J Pediatr. 1992 May;120(5):726–732. doi: 10.1016/s0022-3476(05)80235-5. [DOI] [PubMed] [Google Scholar]

Articles from Archives of Disease in Childhood are provided here courtesy of BMJ Publishing Group

RESOURCES